Corteva, Inc.

LSE:0A1W Stock Report

Market Cap: €37.7b

Corteva Valuation

Is 0A1W undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0A1W when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
€65.09
Fair Value
15.8% undervalued intrinsic discount
23
Number of Analysts

Below Fair Value: 0A1W (€54.8) is trading below our estimate of fair value (€65.09)

Significantly Below Fair Value: 0A1W is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0A1W?

Key metric: As 0A1W is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0A1W. This is calculated by dividing 0A1W's market cap by their current earnings.
What is 0A1W's PE Ratio?
PE Ratio50.1x
EarningsUS$851.00m
Market CapUS$42.65b

Price to Earnings Ratio vs Peers

How does 0A1W's PE Ratio compare to its peers?

The above table shows the PE ratio for 0A1W vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average33.9x
ANTO Antofagasta
26.8x18.9%UK£16.7b
RIO Rio Tinto Group
8.5x-0.5%UK£77.7b
CRDA Croda International
27x14.4%UK£4.3b
FRES Fresnillo
73.3x31.9%UK£7.8b
0A1W Corteva
50.1x24.6%€42.7b

Price-To-Earnings vs Peers: 0A1W is expensive based on its Price-To-Earnings Ratio (50.1x) compared to the peer average (33.9x).

Price to Earnings Ratio vs Industry

How does 0A1W's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0A1W 50.1xIndustry Avg. 16.9xNo. of Companies11PE01020304050+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0A1W is expensive based on its Price-To-Earnings Ratio (50.1x) compared to the European Chemicals industry average (16.2x).

Price to Earnings Ratio vs Fair Ratio

What is 0A1W's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0A1W PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio50.1x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 0A1W's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0A1W forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€54.80
€60.74
+10.8%
6.9%€65.91€51.85n/a23
May ’26€53.76
€60.74
+13.0%
6.9%€65.91€51.85n/a23
Apr ’26€58.56
€64.31
+9.8%
6.7%€69.52€54.69n/a23
Mar ’26n/a
€65.83
0%
7.0%€71.52€54.36n/a22
Feb ’26n/a
€64.43
0%
8.3%€71.07€54.74n/a22
Jan ’26n/a
€64.10
0%
7.9%€71.37€54.98n/a22
Dec ’25n/a
€62.66
0%
6.9%€67.73€54.38n/a22
Nov ’25n/a
€59.21
0%
7.6%€64.72€50.85n/a22
Oct ’25n/a
€56.80
0%
7.3%€62.98€49.48n/a22
Sep ’25n/a
€56.80
0%
7.3%€62.98€49.48n/a22
Aug ’25n/a
€58.64
0%
6.5%€64.87€51.90n/a21
Jul ’25n/a
€58.90
0%
6.8%€65.20€50.30n/a21
Jun ’25n/a
€58.67
0%
6.8%€64.53€49.78n/a20
May ’25n/a
€58.46
0%
7.5%€65.58€49.65€53.7623
Apr ’25n/a
€57.20
0%
7.7%€64.89€49.13€58.5623
Mar ’25n/a
€57.03
0%
7.4%€64.76€49.04n/a24
Feb ’25n/a
€54.44
0%
9.9%€64.40€46.00n/a24
Jan ’25n/a
€53.70
0%
9.6%€65.36€45.52n/a24
Dec ’24n/a
€53.70
0%
9.6%€65.36€45.52n/a24
Nov ’24n/a
€61.88
0%
10.7%€77.24€49.92n/a23
Oct ’24n/a
€65.04
0%
8.2%€77.42€53.82n/a22
Sep ’24n/a
€63.46
0%
8.3%€75.40€52.41n/a22
Aug ’24n/a
€63.13
0%
8.3%€74.13€51.53n/a23
Jul ’24n/a
€65.50
0%
7.2%€75.13€55.89n/a23
Jun ’24n/a
€66.89
0%
7.8%€80.86€56.69n/a22
May ’24n/a
€66.50
0%
8.1%€79.37€54.74n/a21
AnalystConsensusTarget
Consensus Narrative from 23 Analysts
€60.63
Fair Value
9.6% undervalued intrinsic discount
23
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 07:33
End of Day Share Price 2025/05/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Corteva, Inc. is covered by 39 analysts. 22 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
Benjamin TheurerBarclays
Aron CeccarelliBerenberg